News
Illinois Tool Gains From Business Strength Amid Persisting Headwinds
Illinois Tool Works Inc. ITW is poised to gain from positive momentum in the Food Equipment segment. Strength in the institutional, restaurant and food retail markets in North America, along with
Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?
Ironwood Pharmaceuticals’ IRWD sole marketed product, Linzess (linaclotide), has witnessed a strong uptake in recent quarters. The company markets Linzess in the United States in collaboration with
MasTec Stock Down 8% Post Q3 Earnings: Should You Buy the Dip or Fold?
MasTec, Inc. MTZ trended downward 7.9% since reporting its third-quarter 2025 financial results on Oct. 30, underperforming the Zacks Building Products - Heavy Construction industry and the S&P 500
Is Credo Technology's Strong Cash Position a Competitive Advantage?
Credo Technology Group Holding Ltd (CRDO) ended the first quarter of fiscal 2026 strongly, with revenue growth of 274% and a fortified balance sheet, boasting a cash position of $479.6 million.
Walmart Stock Surges After a Solid Q3—Stronger Growth Ahead
Walmart’s (NYSE: WMT) Q3 earnings results and guidance prove that it is on track, taking share from its major competitors like Target (NYSE: TGT), and can sustain its share price uptrend. Among
CNA Stock Trading at a Discount to Industry at 1.11X: Time to Buy?
CNA Financial Corporation CNA shares are trading at a discount compared to the Zacks Property and Casualty Insurance industry. Its forward price-to-book value of 1.11X is lower than the industry
SemRush Buy to Aid Adobe's AI Expertise: What's Ahead for the Stock?
Adobe ADBE has entered into a definitive agreement to acquire Semrush, in an all-cash deal valued at $12 per share, or approximately $1.9 billion. Semrush’s tools for generative engine optimization
Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI
Artificial Intelligence (AI) is no longer confined to the tech sector; it is being aggressively integrated across all industries, from defense to food processing, with healthcare being no exception
NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock?
Shares of Intellia Therapeutics NTLA have witnessed a sharp decline in the past month, primarily due to a regulatory setback faced with one of its lead in vivo candidates, nex-z (formerly known as
Pre-markets Try Again, Begin Session in the Green
Friday, November 21, 2025OK, let’s try this again: pre-market futures are up half a percentage point or more at this hour, with the Dow +259 points, the S&P 500 +34, the Nasdaq +122 and the
How ExxonMobil's Integrated Business Model Supports Dividend Growth
Exxon Mobil Corporation XOM, a leading global energy company, has an integrated business model with robust upstream operations as well as downstream and chemicals businesses. The integrated business
ET Stock Trading at a Discount to Industry at 8.96X: How to Play?
Energy Transfer LP’s ET units are somewhat inexpensive relative to its Zacks Oil and Gas Production Pipeline – MLB industry. ET’s current trailing 12-month Enterprise Value/Earnings before Interest
Spotlight on European ETFs Ahead of Expected BoE December Rate Cut
Anticipation is mounting among financial experts as the Bank of England (BoE) is widely expected to cut interest rates at its December meeting. According to a Reuters poll conducted in November
VinFast Auto Ltd. (VFS) Reports Q3 Loss, Lags Revenue Estimates
VinFast Auto Ltd. (VFS) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.23 per share a year ago. These figures
US Approves $93M Weapon Sale to India: A Boost for Defense ETFs
In a significant boost to U.S.-India strategic ties, the United States has officially approved $93 million in weapon sales to India, covering the supply of up to 100 Javelin anti-tank missiles and
AZN Wins FDA Nod for Expanded Use of Rare Disease Drug, Koselugo
AstraZeneca AZN announced that the FDA has approved its oral, selective MEK inhibitor, Koselugo (selumetinib), for expanded use. The drug is now indicated to treat symptomatic, inoperable plexiform
NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth
Novartis NVS recently held an investor event, wherein management projected sales to grow at a compounded annual growth rate (CAGR) of 5-6% (at constant currencies) for 2025-2030.
Management also
Are Options Traders Betting on a Big Move in Ameriprise Financial Stock?
Investors in Ameriprise Financial, Inc. AMP need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $270 Call had some of the highest
Implied Volatility Surging for Associated Banc-Corp Stock Options
Investors in Associated Banc-Corp ASB need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $5 Call had some of the highest implied
Intuit Q1 Earnings Surpass Estimates, Online Ecosystem Revenues Surge
Intuit INTU reported first-quarter fiscal 2026 non-GAAP earnings per share (EPS) of $3.34, which beat the Zacks Consensus Estimate of $3.10. The bottom line jumped 33.6% from the year-ago
Wall Street Analysts Believe Enanta Pharmaceuticals (ENTA) Could Rally 44.85%: Here's is How to Trade
Shares of Enanta Pharmaceuticals (ENTA) have gained 13.7% over the past four weeks to close the last trading session at $12.13, but there could still be a solid upside left in the stock if
Wall Street Analysts Believe Palomar (PLMR) Could Rally 27.95%: Here's is How to Trade
Palomar (PLMR) closed the last trading session at $121.66, gaining 7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street


